Active Vitamin D3 Treatment Attenuated Bacterial Translocation via Improving Intestinal Barriers in Cirrhotic Rats

Scope Pathological bacterial translocation from the disrupted intestinal barrier leads to substantial complications and mortality in liver cirrhosis. Vitamin D is reported as beneficial to gut barriers in some animal models. However, its effect on cirrhotic bacterial translocation is unknown. The authors aim to investigate the effects of calcitriol on bacterial translocation in cirrhotic rats. Methods and Results Cirrhotic rats are administrated with a 2‐week course of active vitamin D3 (calcitriol, 0.1 μg kg−1 per day) or vehicle by oral gavage after thioacetamide (TAA) injection for 16 weeks. Bacterial translocation, gut permeability, gut microbiota, and associated mechanisms are investigated. Calcitriol treatment significantly attenuates bacterial translocation and reduces intestinal permeability in TAA‐induced cirrhotic rats. It upregulates the expressions of occludin in the small intestine and claudin‐1 in the colon of cirrhotic rats directly independent of intrahepatic status. Even when a short period of calcitriol treatment do not reduce intestinal bacterial overgrowth, it induces a remarkable change of bacterial diversities and enrichment of Muribaculaceae, Bacteroidales, Allobaculum, Anaerovorax, and Ruminococcaceae. Conclusion Calcitriol treatment attenuates intestinal permeability, reduces bacterial translocation, and enriches potentially beneficial gut microbiota in cirrhotic rats that may enable it as a potential therapeutic agent to prevent cirrhotic complications. Calcitriol treatment attenuates intestinal permeability and bacterial translocation in cirrhotic rats with upregulated expressions of tight junction proteins. Calcitriol treatment enriches potentially beneficial taxa of gut microbiota in cirrhotic rats. Calcitriol may have therapeutic potential to reduce cirrhotic infectious complications.